Pharmacogenetic polymorphisms affecting bisoprolol response-Reference-Cited by-同舟云学术

Pharmacogenetic polymorphisms affecting bisoprolol response

Published:2021-10 Issue: Volume:142 Page:112069
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Castaño-Amores Celia,Díaz-Villamarín Xando,Pérez-Gutiérrez Ana María,Antúnez-Rodríguez Alba,Pozo-Agundo Ana,Moreno-Escobar Eduardo,Sánchez-Ramos Jesús Gabriel,Martínez-González Luis Javier,Dávila-Fajardo Cristina Lucía

Funder

Universidad de Granada

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference47 articles.

1. (AEMPS) AEdMyPS. Drug label: Emconcor 2020, Available from: https://cima.aemps.es/cima/dochtml/ft/63046/FT_63046.html.

2. Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity;Ladage;Cardiovasc Ther.,2013

3. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry;Kotseva;Eur. J. Prev. Cardiol.,2019

4. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry;Ferrari;Eur. J. Prev. Cardiol.,2015

5. Differential effect of β-blockers for heart rate control in coronary artery disease;Cordero;Clin. Cardiol.,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients;British Journal of Clinical Pharmacology;2024-06-17

2. Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset;Biomedicines;2024-01-12

3. β1-adrenergic receptor polymorphisms: a possible genetic predictor of bisoprolol response in acute coronary syndrome;Future Science OA;2023-12

4. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome;Biomedicine & Pharmacotherapy;2023-12

5. Growth inhibition, oxidative stress and characterisation of mortality in green algae under the influence of beta-blockers and non-steroidal anti-inflammatory drugs;Science of The Total Environment;2023-10